Coller JK - Search Results

1

The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver.

Coller JK, Krebsfaenger N, Klein K, Endrizzi K, Wolbold R, Lang T, Nüssler A, Neuhaus P, Zanger UM, Eichelbaum M, Mürdter TE. Coller JK, et al. Br J Clin Pharmacol. 2002 Aug;54(2):157-67. doi: 10.1046/j.1365-2125.2002.01614.x. Br J Clin Pharmacol. 2002. PMID: 12207635 Free PMC article.

2

Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.

Coller JK, Somogyi AA, Bochner F. Coller JK, et al. Br J Clin Pharmacol. 1999 Aug;48(2):158-67. doi: 10.1046/j.1365-2125.1999.00005.x. Br J Clin Pharmacol. 1999. PMID: 10417492 Free PMC article.

3

Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometry.

Mürdter TE, Coller J, Claviez A, Schönberger F, Hofmann U, Dreger P, Schwab M. Mürdter TE, et al. Clin Chem. 2001 Aug;47(8):1437-42. Clin Chem. 2001. PMID: 11468234 Clinical Trial.

4

Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours.

Coller JK, Fritz P, Zanger UM, Siegle I, Eichelbaum M, Kroemer HK, Mürdter TE. Coller JK, et al. Histochem J. 2001 Jun;33(6):329-36. doi: 10.1023/a:1012414806166. Histochem J. 2001. PMID: 11758809

5

Oxidative metabolism of tamoxifen to Z-4-hydroxy-tamoxifen by cytochrome P450 isoforms: an appraisal of in vitro studies.

Coller JK. Coller JK. Clin Exp Pharmacol Physiol. 2003 Nov;30(11):845-8. doi: 10.1046/j.1440-1681.2003.03921.x. Clin Exp Pharmacol Physiol. 2003. PMID: 14678248 Review.

6

Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity.

Coller JK, Krebsfaenger N, Klein K, Wolbold R, Nüssler A, Neuhaus P, Zanger UM, Eichelbaum M, Mürdter TE. Coller JK, et al. Br J Clin Pharmacol. 2004 Jan;57(1):105-11. doi: 10.1046/j.1365-2125.2003.01970.x. Br J Clin Pharmacol. 2004. PMID: 14678348 Free PMC article.

7

CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.

Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA. Hutchinson MR, et al. Among authors: coller jk. Br J Clin Pharmacol. 2004 Mar;57(3):287-97. doi: 10.1046/j.1365-2125.2003.02002.x. Br J Clin Pharmacol. 2004. PMID: 14998425 Free PMC article.

8

The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia.

Davies BJ, Coller JK, James HM, Somogyi AA, Horowitz JD, Sallustio BC. Davies BJ, et al. Among authors: coller jk. Br J Clin Pharmacol. 2006 Mar;61(3):321-5. doi: 10.1111/j.1365-2125.2005.02570.x. Br J Clin Pharmacol. 2006. PMID: 16487226 Free PMC article.

9

Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadone.

Coller JK, Joergensen C, Foster DJ, James H, Gillis D, Christrup L, Somogyi AA. Coller JK, et al. Int J Clin Pharmacol Ther. 2007 Jul;45(7):410-7. doi: 10.5414/cpp45410. Int J Clin Pharmacol Ther. 2007. PMID: 17725248

10

TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells.

Buck MB, Coller JK, Mürdter TE, Eichelbaum M, Knabbe C. Buck MB, et al. Among authors: coller jk. Breast Cancer Res Treat. 2008 Jan;107(1):15-24. doi: 10.1007/s10549-007-9526-7. Epub 2007 Feb 15. Breast Cancer Res Treat. 2008. PMID: 18043895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters